Doug Hampton 
MEDSIR PHERGain trial is the first to use an adaptive design in HER2-positive early breast cancer. Tweet this PHERGain is a randomized, controlled phase 2 clinical trial that involved 356 early-stage HER2-positive breast cancer patients from 45 centers in seven European countries. It was sponsored by MEDSIR, a company dedicated to advancing clinical research in … Read more
DUBLIN, June 2, 2023 /PRNewswire/ — The “Genomics Market by Product & Service (Consumables, Instrument, System & Software), Technology (Sequencing, PCR, Microarray), Study Type (Epigenomics, Biomarker Discovery), Application (Drug Discovery, Diagnostic, Agriculture) – Global Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering. The global genomics market is projected to reach USD 83.1 billion … Read more
Company details follow-on Phase 2b study design in head and neck cancer for its lead small molecule candidate, RRx-001 Company also presented positive first-in-human data from its TGF-β trap vector, AdAPT-001 TORREY PINES, Calif., June 2, 2023 /PRNewswire/ — EpicentRx, Inc. (“EpicentRx”), a leading-edge, clinical-stage biopharmaceutical company, today presented clinical progress updates for two lead … Read more
National award signifies a formal commitment to continuous improvementin quality care. LOUISVILLE, Ky., June 2, 2023 /PRNewswire/ — Continuing its mission to become the Best Healthcare Company in the Midwest, 56 Trilogy Health Services communities across four states have been recognized as 2023 recipients of the Bronze – Commitment to Quality Award by the American … Read more
HOUSTON, June 2, 2023 /PRNewswire/ — Allergy & ENT Associates, a leading provider of allergy and ear, nose, and throat (ENT) care, is announcing the opening of its new office in River Oaks. The new office is located at 2415 W Alabama St STE 208 in Houston, Texas, and is open Tuesday through Friday with … Read more
GRANVILLE, Ohio, June 2, 2023 /PRNewswire/ — Better Minds Group, an advanced behavioral health practice in Licking County, announced today that Amy Klinger, MSN, FNP-BC, President of Recovery NP, will be their latest collaborative partner. Amy Klinger, MSN, Family Nurse Practitioner, has over 20 years experience working with clients struggling with a wide array of challenges, … Read more
WALTHAM, Mass., June 2, 2023 /PRNewswire/ — Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that on June 1, 2023 the Company granted inducement awards to purchase up to 397,900 shares of common stock to eighteen new employees under the Company’s 2023 Inducement Plan. The stock … Read more
PHILADELPHIA, June 2, 2023 /PRNewswire/ — More than 500 students from Philadelphia College of Osteopathic Medicine (PCOM) celebrated the culmination of years of hard work and dedication at the College’s 132nd commencement ceremony on May 19 at the Pennsylvania Convention Center in Philadelphia. PCOM Provost and Senior Vice President of Academic Affairs Kenneth J. Veit, … Read more
Clario joins partnership supporting White House Cancer Moonshot Clario brings over 50 years of experience in oncology clinical trials to the partnership and has been involved in over 75% of all FDA approvals of oncology medicines since 2012 Clario scientists have supported nearly 5,000 studies in oncology in over 160,000 sites worldwide involving more than … Read more
Clario joins partnership supporting White House Cancer Moonshot Clario brings over 50 years of experience in oncology clinical trials to the partnership and has been involved in over 75% of all FDA approvals of oncology medicines since 2012 Clario scientists have supported nearly 5,000 studies in oncology in over 160,000 sites worldwide involving more than … Read more